Intelligence · Clinical Development
Pipeline search results
Programs matching “breast-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 272 pipeline programs matching "breast-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
AUY922
Novartis Pharmaceuticals
Advanced HER2-positive Breast Cancer
1 trial -
AZD5363
Cardiff Oncology
Estrogen Receptor Positive Breast Cancer
1 trial -
AZD5363 when combined with weekly paclitaxel.
AstraZeneca
Advanced or Metastatic Breast Cancer
1 trial -
Abraxane
Duke University
Metastatic Breast Cancer
1 trial -
Ad-RTS-hIL-12
Alaunos Therapeutics
Metastatic Breast Cancer
1 trial -
Ad-RTS-hIL-12 and Veledimex
Alaunos Therapeutics
Breast Cancer Nos Metastatic Recurrent
1 trial -
Alpelisib
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Amcenestrant
Sanofi Pasteur
Breast Cancer Metastatic
1 trial -
Anti-HER2 CAR-T
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Apatinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Metastatic
1 trial -
Apatinib
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Azenosertib
Zentalis Pharmaceuticals
Breast Cancer
1 trial -
BC1 cell line
BriaCell Therapeutics
Breast Cancer
1 trial -
BDC-1001
Bolt Biotherapeutics
Metastatic Breast Cancer
1 trial -
Bevacizumab
BRIGHT MINDS BIOSCIENCES INC.
Breast Cancer
1 trial -
Camrelizumab
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Camrelizumab with vinorelbine and cisplatin
The First People's Hospital of Lianyungang
HER2-negative Breast Cancer
1 trial -
Capecitabine
Novartis Pharmaceuticals
Breast Cancer
1 trial -
Capecitabine
PUMA BIOTECHNOLOGY, INC.
Breast Cancer
1 trial -
Capecitabine
Vera Therapeutics
Breast Cancer
1 trial -
Chemotherapy+PD-1 inhibitor+8Gy x 3f
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HR+HER2- Breast Cancer
1 trial -
DC-CIK Immunotherapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
DC1 Vaccine
United Therapeutics Europe Ltd
Breast Cancer Female
1 trial -
Dalpiciclib
The First People's Hospital of Lianyungang
Early Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.